Sidus Space Inc. (SIDU): Nasdaq/NYSE listing notice — Nasdaq to delist Sidus Space; bid price below $0.10 for 10 days; hearing planned

Sidus Space Inc.

Nasdaq notified Sidus on Nov 7, 2023, that bid price was $0.10 or less for 10 consecutive trading days.
Delisting from Nasdaq Capital Market scheduled for Nov 16, 2023, unless hearing is requested.
Company intends to request a hearing, which will stay delisting pending Panel decision and any extension.
Previously, Sidus had until March 11, 2024, to regain compliance with the $1.00 minimum bid price rule.
Common stock (SIDU) to continue trading on Nasdaq at least until hearing process concludes.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Sidus Space Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)(iii)

Exact text from the filing

November 7, 2023, Nasdaq issued a letter to the Company that as of November 6, 2023, it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market, on November 16, 2023, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company intends to request a hearing b

View on SEC.gov

Browse all listing & compliance notices →

Sidus Space Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-040486

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.